Benitec progressing on straightforward way to administer ocular gene therapy; shares rocket 150% – Seeking Alpha
|
Benitec progressing on straightforward way to administer ocular gene therapy; shares rocket 150%
Seeking Alpha Thinly traded nano cap Benitec Biopharma (BNTC +150%) zooms northward on a whopping 47x surge in volume in response to is announcement that it has made significant progress with its ddRNAi technology to treat ocular diseases, particularly with … |
